HCC Screening And Surveillance Risk Biomarkers

Update: 2024-08-29

Description

In his first podcast, Dr. Robert Gish discusses Hepatocellular carcinoma (HCC) Screening And Surveillance Risk Biomarkers, how to use and what to order.

Learn more about Dr. Gish at his website www.robertgish.com and send any questions or feedback to him at rgish@robertgish.com

Dr. Gish will be releasing new podcasts every other week so tune in for more.

Thank you for listening!

Comments

In Channel

When Do I Use Resmetirom for Nonalcoholic Steatohepatitis (NASH)

2025-03-1406:35

Primary Biliary Cholangitis & Second Line Therapy

2025-02-2706:48

Exploring HepQuant DuO - Liver Function Test

2025-02-1307:51

When and How to Use the Direct Bilirubin

2025-01-1603:36

Hepatitis Delta

2025-01-0204:55

Statins in Chronic Liver Disease

2024-12-2103:47

Cuvrior: A New Treatment for Wilson Disease

2024-12-0503:46

How To Use Noninvasive Testing (NITs) in Your Practice Today

2024-11-2204:37

When to Order a Gamma-Glutamyl Transferase (GGT)

2024-11-0704:17

Thromboelastography (TEG)

2024-10-2403:51

Hepatitis B Virus - Treat All Approach

2024-10-1005:28

When and how do you use phosphatidylethanol (PETH) testing in your clinical practice

2024-09-2604:41

Progressive familial intrahepatic cholestasis (PFIC) and genetic testing for cholestatic liver disease

2024-09-1206:29

HCC Screening And Surveillance Risk Biomarkers

2024-08-2904:43

00:00

HCC Screening And Surveillance Risk Biomarkers

#box-pro-ellipsis-176633850116445{-webkit-line-clamp:2;}HCC Screening And Surveillance Risk Biomarkers

HCC Screening And Surveillance Risk Biomarkers

Robert G Gish MD

HCC Screening And Surveillance Risk Biomarkers